Literature DB >> 6322632

NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus.

S Broder, P A Bunn, E S Jaffe, W Blattner, R C Gallo, F Wong-Staal, T A Waldmann, V T DeVita.   

Abstract

Human T-cell leukemia/lymphoma virus is a unique family of T-cell tropic, human, type-C retroviruses. The discovery of this class of retroviruses provides the first proven link between retroviruses and cancer in humans. This virus is endemic in certain parts of the world, including the southeastern United States, and is associated with the development of adult T-cell leukemia/lymphoma, a fulminant lymphoproliferative disorder frequently accompanied by opportunistic infections and hypercalcemia. Over the last few years, major advances have been made in understanding the clinical, epidemiologic, molecular biologic, and immunologic features of this unique class of human RNA tumor viruses.

Entities:  

Mesh:

Year:  1984        PMID: 6322632     DOI: 10.7326/0003-4819-100-4-543

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Adult T cell leukemia lymphoma.

Authors:  Lee Ratner
Journal:  Front Biosci       Date:  2004-09-01

2.  Internal medicine: human T-cell leukemia virus (HTLV).

Authors:  S M Neely; A M Levine
Journal:  West J Med       Date:  1985-07

3.  Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Authors:  Jonathan L Berkowitz; John E Janik; Donn M Stewart; Elaine S Jaffe; Maryalice Stetler-Stevenson; Joanna H Shih; Thomas A Fleisher; Maria Turner; Nicole E Urquhart; Gilian H Wharfe; William D Figg; Cody J Peer; Carolyn K Goldman; Thomas A Waldmann; John C Morris
Journal:  Clin Immunol       Date:  2014-09-28       Impact factor: 3.969

4.  Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.

Authors:  Kamal Sharma; John E Janik; Deirdre O'Mahony; Donn Stewart; Stefania Pittaluga; Maryalice Stetler-Stevenson; Elaine S Jaffe; Mark Raffeld; Thomas A Fleisher; Cathryn C Lee; Seth M Steinberg; Thomas A Waldmann; John C Morris
Journal:  Clin Cancer Res       Date:  2016-08-02       Impact factor: 12.531

6.  The acquired immunodeficiency syndrome and hypercalcemia.

Authors:  M B Jacobs
Journal:  West J Med       Date:  1986-04

7.  How viruses suppress immunity.

Authors:  R E Lee
Journal:  Can Med Assoc J       Date:  1984-12-15       Impact factor: 8.262

8.  HTLV-1: A Significant Retrovirus.

Authors:  R D Gascoyne
Journal:  Can Fam Physician       Date:  1988-11       Impact factor: 3.275

Review 9.  Adult T-cell leukemia-lymphoma.

Authors:  S M Neely
Journal:  West J Med       Date:  1989-05

10.  Acetylation and oxidation phenotypes in malignant lymphoma.

Authors:  P A Philip; H J Rogers; P G Harper
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.